﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>14</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>03</Month>
        <DAY>07</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The Simultaneous Effects of miR-145-5p and hsa-let-7a-3p on Colorectal Tumorigenesis: In Vitro Evidence</ArticleTitle>
    <FirstPage>231</FirstPage>
    <LastPage>240</LastPage>
    <ELocationID EIdType="doi">10.34172/apb.2024.004</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nazila</FirstName>
        <LastName>Mozammel</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0951-2606</Identifier>
      </Author>
      <Author>
        <FirstName>Elham</FirstName>
        <LastName>Baghbani</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Amini</LastName>
      </Author>
      <Author>
        <FirstName>Sheyda</FirstName>
        <LastName>Jodeiry Zaer</LastName>
      </Author>
      <Author>
        <FirstName>Yalda</FirstName>
        <LastName>Baghay Esfandyari</LastName>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Tohidast</LastName>
      </Author>
      <Author>
        <FirstName>Seyed Samad</FirstName>
        <LastName>Hosseini</LastName>
      </Author>
      <Author>
        <FirstName>Seyed Ali</FirstName>
        <LastName>Rahmani</LastName>
      </Author>
      <Author>
        <FirstName>Ahad</FirstName>
        <LastName>Mokhtarzadeh</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-4515-8675</Identifier>
      </Author>
      <Author>
        <FirstName>Behzad</FirstName>
        <LastName>Baradaran</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-8642-6795</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/apb.2024.004</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>11</Month>
        <Day>16</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>07</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: MicroRNAs (miRNAs) are a group of small regulatory non-coding RNAs, which are dysregulated through tumor progression. let-7 and MIR-145 are both tumor suppressor microRNAs that are downregulated in a wide array of cancers including colorectal cancer (CRC). Methods: This study was aimed to investigate the effect of simultaneous replacement of these two tumor suppressor miRNAs on proliferation, apoptosis, and migration of CRC cells. HCT-116 with lower expression levels of hsa-let-7a-3p and MIR-145-5p was selected for functional investigations. The cells were cultured and transfected with hsa-let-7a and MIR-145, separately and in combination. Cell viability and apoptosis rates were assessed by MTT assay and flow cytometry, respectively. Cell cycle status was further evaluated using flow cytometry and qRT-PCR was employed to evaluate gene expression. Results: The obtained results showed that exogenous overexpression of MIR-145 and hsa-let-7a in HCT-116 cells could cooperatively decrease CRC cell proliferation and induce sub-G1 cell cycle arrest. Moreover, hsa-let-7a and MIR-145 co-transfection significantly increased apoptosis induction compared to separate transfected cells and control through modulating the expression levels of apoptosis-related genes including Bax, Bcl-2, P53, Caspase-3, Caspase-8, and Caspase-9. Furthermore, qRT-PCR results illustrated that hsa-let-7a and MIR-145 combination more effectively downregulated MMP-9 and MMP-2 expression, as the important modulators of metastasis, compared to the controls. Conclusion: Taken together, considering that exogenous overexpression of MIR-145 and hsa-let-7a showed cooperative anti-cancer effects on CRC cells, their combination may be considered as a novel therapeutic strategy for the treatment of CRC.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Colorectal cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MIR-145-5p</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">hsa-let-7a-3p</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>